Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The follicle-stimulating hormone receptor (FSHR) is a transmembrane protein belonging to the G protein-coupled receptor (GPCR) superfamily. It specifically binds follicle-stimulating hormone (FSH), a glycoprotein hormone essential for reproductive processes in both males and females. FSHR activation is necessary for the hormonal actions of FSH, including regulation of gametogenesis, folliculogenesis, oocyte maturation in females, and spermatogenesis in males. Emerging evidence suggests additional roles outside gonadal tissues—including potential involvement in cancer biology, fat metabolism, and bone density regulation—but these are less well characterized compared to its reproductive functions.
FSH binds to FSHR, triggering conformational changes and activating intracellular G proteins, leading to downstream signaling cascades such as cAMP production through adenylate cyclase activation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Follicle Stimulating Hormone Receptor (None).